Ten63 Therapeutics, Inc. — Form D
Ten63 Therapeutics, Inc. of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2021-01-27. The offering totals $2.1M, of which $2.1M was reported sold. Industry: Other.
Offering
- Filed: 2021-01-27
- Form: D
- Accession: 0001231919-21-000006
- Industry: Other
- Exemptions: 06b
- Total offering: $2.1M
- Amount sold: $2.1M
- Investors: 7
- Date of first sale: 2021-01-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-387500
Issuer
- Name: Ten63 Therapeutics, Inc.
- CIK: 0001841954
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 110 N CORCORAN STREET, DURHAM, NC, 27701
- Phone: 919-263-4218
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Marcel Frenkel | Director | DURHAM, NC |
| Mark A Hallen | Director | DURHAM, NC |
| Damien A Petty | Director | DURHAM, NC |
| Jia Wei A Xu | Director | DURHAM, NC |
| Marcel Frenkel | Executive Officer | DURHAM, NC |
| Mark A Hallen | Executive Officer | DURHAM, NC |
More